Does Graves’ Orbitopathy Ever Disappear Answers to an Old Question-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does Graves’ Orbitopathy Ever Disappear Answers to an Old Question

Published:2017 Issue:5 Volume:6 Page:263-270
ISSN:2235-0640
Container-title:European Thyroid Journal
language:en
Short-container-title:Eur Thyroid J

Author:

Sabini Elena,Leo Marenza,Mazzi Barbara,Rocchi Roberto,Latrofa Francesco,Nardi Marco,Vitti Paolo,Marcocci Claudio,Marinò Michele

Publisher

Bioscientifica

Subject

Endocrinology, Diabetes and Metabolism

Reference22 articles.

1. Bahn RS: Graves’ ophthalmopathy. N Engl J Med 2010; 362: 726–738.

2. Bartalena L: Diagnosis and management of Graves’ disease: a global overview. Nat Rev Endocrinol 2013; 9: 724–734.

3. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM; European Group on Graves’ Orbitopathy (EUGOGO) European Group on Graves’ Orbitopathy (EUGOGO): The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy. Eur Thyroid J 2016; 5: 9–26.

4. Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F, Gaiti M, Spreafico E, Gallo D, Premoli P, Piantanida E, Tanda ML, Ferrario M, Vitti P, Chiovato L: The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study. J Endocrinol Invest 2016; 39: 1445–1451.

5. Perros P, Crombie AL, Kendall-Taylor P: Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 1995; 42: 45–50.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials;Thyroid®;2024-07-01

2. Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves’ orbitopathy;International Ophthalmology;2024-02-12

3. Cosmetic Surgery for Thyroid-Associated Orbitopathy;Oculoplastic, Lacrimal and Orbital Surgery;2024

4. Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity;The Journal of Clinical Endocrinology & Metabolism;2023-10-31

5. Long-Term Follow-up of Graves Orbitopathy After Treatment With Short- or Long-Term Methimazole or Radioactive Iodine;Endocrine Practice;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3